Category: stock

  • Donaldson Co. chief legal officer sells $1.05m in stock By Investing.com

    In a recent transaction, Amy C. Baker, Chief Legal Officer of Donaldson, Inc. (NYSE: DCI), a leading provider of industrial and commercial air purification equipment, sold shares of the company’s stock for approximately $1.05 million. The transaction occurred on September 19, 2024, and involved the sale of 14,500 shares at…

  • After Its Reverse Stock Split, Is SiriusXM Satellite Radio a Buy?

    Sirius XM Holdings (NASDAQ: Siri) It was launched nearly a generation ago with big plans to change the media. Fast forward to 2024, and it seems that these plans have failed to achieve their goals. Internet-based alternatives such as Spotify SiriusXM outperforms SiriusXM in audience size and market cap, and…

  • Natera co-founder sells over $2.8 million in company stock By Investing.com

    In a recent transaction, Sheena Jonathan, co-founder of Natera, Inc. (NASDAQ:), a leading personal genetic testing and diagnostics company, sold a significant amount of the company’s stock. The total sale, which took place on September 18, 2024, was more than $2.8 million. The transactions involved the sale of several blocks…

  • This $80 Billion Market Could Be the Next Big Growth Driver for Nvidia Stock

    Graphics processing units (GPUs) have been created. Nvidia‘s (NASDAQ: NVDA) Intel has been in the bread and butter business for a very long time. Initially, the company made its name by producing graphics processing units (GPUs) for use in gaming and content creation PCs, before eventually gaining fame with its…

  • Eliem therapeutics executive sells over $9,000 in company stock By Investing.com

    According to a new filing with the U.S. Securities and Exchange Commission, Emily Pimblett, chief accounting officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), recently sold a portion of her company’s stock. The transactions, which took place on September 20, 2024, involved the sale of 1,182 shares at $8.18 each and 9…

  • Eliem therapeutics executive sells over $9,000 in company stock By Investing.com

    According to a new filing with the U.S. Securities and Exchange Commission, Emily Pimblett, chief accounting officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), recently sold a portion of her company’s stock. The transactions, which took place on September 20, 2024, involved the sale of 1,182 shares at $8.18 each and 9…

  • Intel stock jumps on Qualcomm’s takeover approach

    Intel shares rose after the Wall Street Journal reported that Qualcomm Inc. had approached the company about acquiring it, a potential record deal for the chipmaker. The discussions took place in recent days, the newspaper reported, citing people familiar with the situation. However, a deal is not certain, according to…

  • RENN Fund CEO Murray Stahl buys $2,704 worth of company stock By Investing.com

    In a recent deal completed on September 19, Murray Stahl, Chairman and CEO of RENN Fund, Inc. (NYSE:RCG), increased his stake in the company. The deal involved the purchase of shares at $1.98 per share, for a total value of $2,704. Stahl’s move demonstrates his increased investment in the company,…

  • FedEx stock target cut on demand concerns, retains buy rating By Investing.com

    On Friday, TD Cowen took a cautious stance on FedEx Corp (NYSE: ) shares by cutting its price target to $328 from $334, while still recommending the stock as a Buy. The revision comes on the heels of FedEx’s first-quarter financial results, which fell short of analyst expectations or the…

  • Alice Walton sells over $170 million in Walmart stock By Investing.com

    In a notable move in the retail sector, Alice Walton, a major shareholder in Walmart Inc. (NYSE: ), has sold a significant portion of her stake in the company. Recent transactions revealed that Walton sold a total of 2,219,617 shares of Walmart stock, worth more than $170 million. The sales…

  • ACV auctions executive sells $1.5 million in company stock By Investing.com

    According to a recent filing with the Securities and Exchange Commission, Michael Waterman, chief sales officer of ACV Auctions Inc. (NASDAQ:ACVA), sold 75,000 shares of the company’s stock. The shares were sold on September 17, 2024, at an average price of $20.24, for a total net proceeds of approximately $1.5…

  • Abbott Labs stock ‘attractive entry’ amid NEC litigation overhang

    On Thursday, Piper Sandler began covering Abbott Laboratories (NYSE:NYSE:) stock, assigning an Overweight rating and a $131 price target. The company highlighted the company’s strong performance, but noted that the stock has underperformed year-to-date, largely due to ongoing litigation related to necrotizing enterocolitis (NEC). However, the company believes that the…

  • Bitcoin Exchange On The Horizon For Europe’s 3rd Biggest Stock Exchange

    This article is also available in Spanish. According to the Financial Times, the Swiss Stock Exchange SIX, Europe’s third-largest stock exchange, is considering launching a new Bitcoin and cryptocurrency exchange in the country, with the aim of positioning itself to compete with exchanges such as Binance, OKX and Coinbase. SIX…

  • Bitcoin Exchange On The Horizon For Europe’s 3rd Biggest Stock Exchange

    This article is also available in Spanish. According to the Financial Times, the Swiss Stock Exchange SIX, Europe’s third-largest stock exchange, is considering launching a new Bitcoin and cryptocurrency exchange in the country, with the aim of positioning itself to compete with exchanges such as Binance, OKX and Coinbase. SIX…

  • Terns Pharmaceuticals director buys $5 million in company stock By Investing.com

    In a recent deal, Hongbo Lu, a director at Terns Pharmaceuticals, Inc. (NASDAQ:TERN), bought a significant amount of the company’s stock, signaling a strong vote of confidence in the company’s future prospects. The deal, which closed on September 12, involved the acquisition of 476,190 shares at $10.50 per share, for…

  • Terns Pharmaceuticals director buys $5 million in company stock By Investing.com

    In a recent deal, Hongbo Lu, a director at Terns Pharmaceuticals, Inc. (NASDAQ:TERN), bought a significant amount of the company’s stock, signaling a strong vote of confidence in the company’s future prospects. The deal, which closed on September 12, involved the acquisition of 476,190 shares at $10.50 per share, for…

  • Nutanix CFO sells over $1.4m in company stock By Investing.com

    Nutanix, Inc. (NASDAQ:) CFO Sivaraman Rukmini recently sold a significant portion of the company’s stock, as disclosed in a recent filing with the Securities and Exchange Commission. The transactions, which took place on September 17, 2024, involved the sale of 20,368 shares at a weighted average price of $58.7452, and…

  • Peloton CFO Elizabeth Coddington sells $174k in company stock By Investing.com

    In a recent move, Elizabeth F. Coddington, CFO of Peloton Interactive, Inc. (NASDAQ:), sold a significant portion of her company’s stock. The deal, which took place on September 16, 2024, involved the sale of 36,819 shares at a weighted average price of $4.63 to $4.82, resulting in a total value…

  • GGR stock touches 52-week low at $0.83 amid market challenges By Investing.com

    In a challenging market environment, Poema Global Holdings (GGR) stock hit a 52-week low, dropping to $0.83. This significant decline reflects a broader trend for the company, which has seen its stock value decline by 67.68% over the past year. Investors have been cautious as the company navigates a period…

  • Intel pleases stock market, but Chinese lie in wait

    Yesterday, Intel CEO Pat Gelsinger nearly uttered the word he had been unable to utter in his three years on the job: “spin off.” The CEO, who had devoted himself to Intel’s business unit, could not bear the idea, and he probably also recognized the regulatory and business difficulties that…